BACE1 and early-onset autosomal dominant Alzheimer disease: Du et al. (52) shows that blocking the beta-secretase 1 (BACE1) enzyme can help clear the Aβ plaques, as thorough studies indicate that a high dosage of SY can also reduce BACE1 activity in Alzheimer’s disease mouse models.